Bharat Biotech is a leading Indian biotechnology company. It focuses on developing vaccines and biotherapeutics. Founded in 1996, it has made significant contributions to public health. The company is known for its innovative research and development. It has produced vaccines for diseases like typhoid and COVID-19. Bharat Biotech plays a crucial role in India's healthcare landscape. Its work supports the nation's fight against infectious diseases.
The state government of Karnataka is planning to set up a Pandemic Preparedness Innovation Centre (PPIC) to tackle the challenges posed by pandemics on humans, animals, and the...
Bharat Biotech's intranasal COVID-19 vaccine, also known as iNCOVACC or BBV154, has been approved for use in India as a booster dose for those over 18 years of...
India may soon begin testing the efficacy of two different Covid-19 vaccines which are mixed together to see if it helps boost the immune response to the Covid-19...
The Government of India has decided to provide support to some public sector companies by advancing them grants so as to boost Covid-19 vaccine production under the Mission...
Prime Minister Narendra Modi took the first shot of the COVAXIN vaccine on March 1 at the All India Institute of Medical Sciences (AIIMS) in New Delhi. PM...
India is set to start the COVID-19 vaccination drive from January 16. In order to create faith among the people for the two approved vaccines in the country,...
The Directorate General of Civil Aviation (DGCA), the country's civil aviation regulator, has notified guidelines for airlines and other aircraft operators for the transportation of Covid-19 vaccines. Key...
The developer of indigenous COVID-19 vaccine, Bharat Biotech, has applied to the central drug regulator (DCGI) and asked for the permission of emergency use authorisation for its vaccine...
Bharat Biotech has announced commencement of Phase III trials of India's indigenous COVAXIN vaccine on November 16, 2020.HighlightsThe Phase III trials of COVAXIN would involve 26,000 volunteers from...
The Central Drugs Standard Control Organisation (CDSCO), a prominent health authority in India, has given the green light to Bharat Biotech to initiate human clinical trials for its...
